| P2093 | author name string | Thomas Hartung | |
| | Christoph Funk | |
| | Simone Schadt | |
| | Gerard Greig | |
| | Navita L Mallalieu | |
| | Manfred Zell | |
| | Elena Guerini | |
| | Christophe Husser | |
| | Andreas Gloge | |
| | Ruth Haas | |
| P2860 | cites work | A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. | Q54061742 |
| | A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression | Q29617914 |
| | Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression | Q30572014 |
| | What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs | Q33278984 |
| | Practical Experience of Using Human Microdosing with AMS Analysis to Obtain Early Human Drug Metabolism and PK Data | Q33748891 |
| | The use of isotopes in the determination of absolute bioavailability of drugs in humans | Q34550493 |
| | Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression | Q35111592 |
| | Signaling pathways underlying the rapid antidepressant actions of ketamine | Q35375293 |
| | Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond | Q36899381 |
| | Microdosing: A Valuable Tool for Accelerating Drug Development and The Role of Bioanalytical Methods in Meeting The Challenge | Q37810137 |
| | New ultrasensitive detection technologies and techniques for use in microdosing studies | Q37810198 |
| | Novel strategies for microdose studies using non-radiolabeled compounds | Q37846274 |
| | Emerging drugs for major depressive disorder | Q37984619 |
| | mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants | Q38013871 |
| | Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism | Q41444088 |
| | Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients | Q44710965 |
| | The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers | Q46711334 |
| | A double-blind, placebo-controlled study of memantine in the treatment of major depression | Q46877857 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 144-153 | |
| P577 | publication date | 2016-04-28 | |
| P1433 | published in | Xenobiotica | Q1360678 |
| P1476 | title | A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [13C6]-labeled b | |
| P478 | volume | 47 | |